Skip to main content
. 2022 Jun 13;24(6):e34307. doi: 10.2196/34307

Table 2.

Characteristics of the studies (N=72).



References
Participants

Stroke survivors [21,23,25,26,28-30,32-34,38,40,44-47,51,52,54,56,58,60,62,65,67,69,71,73,74,76,77,79,80,82,85,86,90]

Healthy participants [20,31,39,42,43,55,59,61,78]

Stroke survivors and healthy participants [22,24,27,35-37,41,48-50,53,57,63,64,66,68,70,72,75,81,83,84,87-89]
Stage of recovery

Subacute [35,73,82,89]

Chronic [21,23,26-30,32-34,38,40,41,44,46,47,51,52,56,58,60,62,65,68,69,71,74,75,79,80,83-85,87,88,90]

Subacute and chronic [22,24,25,36,37,45,50,53,54,57,63,64,66,67,72,77,86,91]